Zevra Therapeutics ZVRA
NASDAQ ZVRA
$11.85 -0.07 (-0.59%)
At close: Nov 11, 2026 · 4:00 PM EST

Zevra Therapeutics (ZVRA) Work In Process (2023 - 2024)

Updated

Zevra Therapeutics' Work In Process was $3.08 million in Q3 2024, down 7.1% from the prior quarter.

Analysis

Zevra Therapeutics (ZVRA) Work In Process (2023 - 2024) Analysis & Trends

At the end of FY2023, Work In Process at Zevra Therapeutics came in at $1.88 million.

  • Quarterly Work In Process has moved between $1.88 million (Q4 2023) and $3.32 million (Q2 2024) over five years.
  • Per Business Quant data, ZVRA's Work In Process in the three quarters before Q3 2024 was $3.32 million (Q2 2024), $3.31 million (Q1 2024) and $1.88 million (Q4 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Zevra Therapeutics 708.52 Mn -100.24 Mn 36.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 3.08 Mn
Jun 30, 2024 3.32 Mn
Mar 31, 2024 3.31 Mn
Dec 31, 2023 1.88 Mn
API Access

Zevra Therapeutics Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=ZVRA&period=max&api_key=YOUR_API_KEY